Emerging Infectious Diseases (Nov 2022)

CDC’s COVID-19 International Vaccine Implementation and Evaluation Program and Lessons from Earlier Vaccine Introductions

  • Heidi M. Soeters,
  • Reena H. Doshi,
  • Monica Fleming,
  • Oluwasegun Joel Adegoke,
  • Uzoamaka Ajene,
  • Brooke Noel Aksnes,
  • Sarah Bennett,
  • Erin F. Blau,
  • Julie Garon Carlton,
  • Sara Clements,
  • Laura Conklin,
  • Melissa Dahlke,
  • Lindsey M. Duca,
  • Leora R. Feldstein,
  • Jane F. Gidudu,
  • Gavin Grant,
  • Margaret Hercules,
  • Ledor S. Igboh,
  • Atsuyoshi Ishizumi,
  • Sara Jacenko,
  • Yinka Kerr,
  • Nuadum M. Konne,
  • Shibani Kulkarni,
  • Archana Kumar,
  • Kathryn E. Lafond,
  • Eugene Lam,
  • Ashley T. Longley,
  • Margaret McCarron,
  • Apophia Namageyo-Funa,
  • Nancy Ortiz,
  • Jaymin C. Patel,
  • Robert T. Perry,
  • Dimitri Prybylski,
  • Prianca Reddi,
  • Omar Salman,
  • Courtney N. Sciarratta,
  • Talya Shragai,
  • Akshita Siddula,
  • Ester Sikare,
  • Dieula Delissaint Tchoualeu,
  • Denise Traicoff,
  • Alexandra Tuttle,
  • Kerton R. Victory,
  • Aaron Wallace,
  • Kirsten Ward,
  • Man Kai Alyssa Wong,
  • Weigong Zhou,
  • W. William Schluter,
  • David L. Fitter,
  • Anthony Mounts,
  • Joseph S. Bresee,
  • Terri B. Hyde

DOI
https://doi.org/10.3201/eid2813.212123
Journal volume & issue
Vol. 28, no. 13
pp. 208 – 216

Abstract

Read online

The US Centers for Disease Control and Prevention (CDC) supports international partners in introducing vaccines, including those against SARS-CoV-2 virus. CDC contributes to the development of global technical tools, guidance, and policy for COVID-19 vaccination and has established its COVID-19 International Vaccine Implementation and Evaluation (CIVIE) program. CIVIE supports ministries of health and their partner organizations in developing or strengthening their national capacities for the planning, implementation, and evaluation of COVID-19 vaccination programs. CIVIE’s 7 priority areas for country-specific technical assistance are vaccine policy development, program planning, vaccine confidence and demand, data management and use, workforce development, vaccine safety, and evaluation. We discuss CDC’s work on global COVID-19 vaccine implementation, including priorities, challenges, opportunities, and applicable lessons learned from prior experiences with Ebola, influenza, and meningococcal serogroup A conjugate vaccine introductions.

Keywords